Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cachexia × Fundoplication × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Hernia, Hiatal 1 Gastroesophageal Reflux 1 Esophagitis 1 Deglutition Disorders 1 Cachexia 1 Barrett Esophagus 1

Interventions

Megestrol Acetate 9 Exercise 5 Standard of Care 4 Olanzapine 3 Blood Specimen Collection 3 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Infliximab 2 Ibuprofen 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 dermcidin 1 clazakizumab 1 bermekimab 1 Vitamin D 1 Sodium Chloride 1 Radiotherapy 1 Pentoxifylline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05128318 2024-05-09

TuLip

Université Catholique de Louvain

Phase NA Terminated

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡